isoproterenol has been researched along with lisinopril in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dandona, P; Fonseca, V; Gill, J; Jeremy, JY | 1 |
| Antunes-Rodrigues, J; Camargo, LA; de Luca Júnior, LA; Renzi, A; Saad, WA | 1 |
| Auch-Schwelk, W; Dümmler, U; Fleck, E; Graf, K; Gräfe, M; Kunkel, G; O'Connor, A; Regitz-Zagrosek, V | 1 |
| Camargo, LA; Luiz, AC; Menani, JV; Renzi, A; Saad, WA; Silveira, JE | 1 |
| Canan, BD; Chimanji, NS; Delfín, DA; Ganguly, R; Janssen, PM; Martin, CD; Mays, TA; Murray, JD; Rafael-Fortney, JA; Raman, SV; Schill, KE; Stangland, JE; Tran, T; Xu, Y | 1 |
1 review(s) available for isoproterenol and lisinopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for isoproterenol and lisinopril
| Article | Year |
|---|---|
Lisinopril and nifedipine administration inhibits the ex vivo uptake of [45Ca2+] by platelets from hypertensive diabetic patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Platelets; Bucladesine; Calcium; Diabetes Complications; Diabetes Mellitus; Enalapril; Epinephrine; Female; Humans; Hypertension; Isoproterenol; Lisinopril; Male; Middle Aged; Nifedipine | 1992 |
6 other study(ies) available for isoproterenol and lisinopril
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Alterations in the water intake caused by central inhibition of angiotensin-converting enzyme in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cerebral Ventricles; Drinking Behavior; Enalapril; Injections, Intraventricular; Injections, Subcutaneous; Isoproterenol; Lisinopril; Male; Rats; Reference Values; Saline Solution, Hypertonic; Time Factors | 1992 |
Regulation of beta-adrenergic receptors on endothelial cells in culture.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cattle; Cells, Cultured; Cyclic AMP; Down-Regulation; Endothelium, Vascular; Isoproterenol; Lisinopril; Radioligand Assay; Ramipril; Receptors, Adrenergic, beta; Up-Regulation | 1993 |
Central angiotensin converting enzyme-blockade and thirst.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Drinking; Injections, Subcutaneous; Isoproterenol; Lisinopril; Male; Polyethylene Glycols; Preoptic Area; Rats; Saline Solution, Hypertonic; Thirst; Time Factors | 1993 |
Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.
Topics: Animals; Cardiac Imaging Techniques; Cardiomyopathies; Cardiotonic Agents; Disease Models, Animal; Diuretics; Isoproterenol; Lisinopril; Magnetic Resonance Imaging; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Myocardium; Spironolactone | 2011 |